Literature DB >> 23275121

Acute promyelocytic leukemia with t(15;17) and two previously unreported additional cytogenetic abnormalities.

Armin Rashidi, Stephen I Fisher.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 23275121     DOI： 10.1007/s12032-012-0392-8

Source DB:  PubMed          Journal:  Med Oncol        ISSN： 1357-0560            Impact factor:   3.064


× No keyword cloud information.
  4 in total

1.  Prognostic implications of additional chromosome abnormalities among patients with de novo acute promyelocytic leukemia with t(15;17).

Authors:  Peter H Wiernik; Zhuoxin Sun; Holly Gundacker; Gordon Dewald; Marilyn L Slovak; Elisabeth Paietta; Haesook T Kim; Frederick R Appelbaum; Peter A Cassileth; Martin S Tallman
Journal:  Med Oncol       Date:  2012-05-22       Impact factor: 3.064

2.  AIDA (all-trans retinoic acid + idarubicin) in newly diagnosed acute promyelocytic leukemia: a Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA) pilot study.

Authors:  G Avvisati; F Lo Coco; D Diverio; M Falda; F Ferrara; M Lazzarino; D Russo; M C Petti; F Mandelli
Journal:  Blood       Date:  1996-08-15       Impact factor: 22.113

3.  Patients with de novo acute myeloid leukaemia and complex karyotype aberrations show a poor prognosis despite intensive treatment: a study of 90 patients.

Authors:  C Schoch; T Haferlach; D Haase; C Fonatsch; H Löffler; B Schlegelberger; P Staib; M C Sauerland; A Heinecke; T Büchner; W Hiddemann
Journal:  Br J Haematol       Date:  2001-01       Impact factor: 6.998

4.  Establishing the presence of the t(15;17) in suspected acute promyelocytic leukaemia: cytogenetic, molecular and PML immunofluorescence assessment of patients entered into the M.R.C. ATRA trial. M.R.C. Adult Leukaemia Working Party.

Authors:  D Grimwade; K Howe; S Langabeer; L Davies; F Oliver; H Walker; D Swirsky; K Wheatley; A Goldstone; A Burnett; E Solomon
Journal:  Br J Haematol       Date:  1996-09       Impact factor: 6.998
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.